2020
DOI: 10.1016/j.jbiosc.2020.06.010
|View full text |Cite
|
Sign up to set email alerts
|

Peptide array-based inhibition ELISA for evaluating antigenicity in infant formulas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…It has been further developed to detect IgG4-epitopes as well [41], to predict safety and efficacy of e.g. oral immunotherapy with CM [42] and to evaluate antigenicity of CM hydrolysates [43]. After full validation and a link to clinical relevance this could be a promising technique to be used in the near future.…”
Section: Antigenicity Assessmentmentioning
confidence: 99%
“…It has been further developed to detect IgG4-epitopes as well [41], to predict safety and efficacy of e.g. oral immunotherapy with CM [42] and to evaluate antigenicity of CM hydrolysates [43]. After full validation and a link to clinical relevance this could be a promising technique to be used in the near future.…”
Section: Antigenicity Assessmentmentioning
confidence: 99%